A vaccine developed with the aim of protecting against pregnancy-associated malaria was found safe in an early clinical trial. Malaria in pregnancy has major impacts on mother and child health. The current strategy to prevent pregnancy-associated malaria (PAM) comprises intermittent preventive treatment and use of insecticidal nets. The new vaccine developed by a team of researchers at the University of Copenhagen in Denmark passed the test by inducing the right antibody response in the blood according to a study published in the journal Clinical Infectious Diseases. It is a great milestone for us to be able to show that our
